Research & Projects

ESCMID Panorama

ESCMID Fungal Infection Study Group - EFISG

News & Activities

10 May 2017

Update on the medical guideline "Diagnosis and management of Aspergillus disease" - in publication process

The draft guideline was under public consultation from 28 March to 09 May 2017.

Once the current manuscript is published, it will appear here along with the comments from the public consultation phase and the author's responses to them.

This guideline is coordinated by the ESCMID Fungal Infection Study Group (EFISG)

28 March 2017

Guideline on the diagnosis and management of Aspergillus disease open for public consultation

The draft version of the medical guideline on the diagnosis and treatment of Aspergillus disease has now entered into the public consultation phase. The guideline is a result of the concerted efforts of ESCMID, through its fungal infections study group (EFISG), the European Confederation of Medical Mycology (ECMM) and the European Respiratory Society (ERS).


Those of you wishing to comment on the manuscript may write to the ESCMID Publications and Medical Guidelines Manager to request the (confidential) draft of the manuscript along with the comments form for listing feedback. We are happy to receive your feedback and comments on the manuscript until 09 May 2017. Please be aware that your comments and the authors’ responses to the comments will be made available online once the guideline is published.

03 February 2017

News on Candida auris

Candida auris is a new species of Candida that is currently causing outbreaks in healthcare settings worldwide. The first outbreak in Europe was described in England in 2015, but there are already cases in Spain.
C. auris is difficult to identify with classical methods and can be misidentified with different species (Rhodotorula glutinis, Saccharomyces cerevisiae, Candida haemulonii, Candida sake, or other species of Candida non-albicans), according to the identification method used. Correct identification can be done by sequencing the ITS or D1-D2 regions or with MALDI-TOF (the species has been included in the last update of Bruker´s library).
C. auris is resistant to fluconazole, and strains resistant to amphotericin B and echinocandins have also been described. From the experience acquired so far, it is known that it is important to detect it as soon as possible to take control measures, due to its high transmission capacity and resistance pattern.
Due to the difficulty of the correct identification of C. auris, if proper identification methods are not available we recommend the referral of suspected invasive isolates to a reference mycology laboratory.
For more information you can visit the following links:

  • Risk Assessment of the European Center for Disease Control (ECDC, direct link)
  • Guidance for the laboratory investigation, management and infection prevention and control from cases of Candida auris elaborated by Public Health England (PHE, direct link)
  • CDC Candida auris website with links to Interim Recommendations, as well as links to papers on a global WGS analysis and investigation of the first seven US cases
  • ECCMID 2017 will present new data on this new pathogen. Check the scientific programme, which will be published on the congress website in the course of February
  • Become EFISG member to stay updated on new developments in the fungal field

- The EFISG Executive Committee

01 November 2016

EFISG comments on JAC supplement on antifungal stewardship

The Journal of Antimicrobial Chemotherapy on 2 November published a supplement on antifungal stewardship, which is a core element in patient care at hospitals. EFISG welcomes and supports this initiative and takes this opportunity to highlight these specific recommendations on antifungal stewardship (online access to this supplement). You may have a look at the supplement's table of content as well as EFISG's comment.

Here is the new EFISG Executive Committee:

  • Cornelia Lass-Flörl, Austria (Chairperson)
  • Sevtap Arikan-Akdagli, Turkey (Secretary)
  • Ana Alastruey-Izquierdo, Spain (Treasurer)

We thank all previous Executive Committee for their excellent work over the last years. We are looking forward to continuing this work.

Your new Executive Committee


This is a database project for analysis of rare fungal infections under the auspices of EFISG, ISHAM and other scientific societies.


Download the latest Annual Report.